PANORAMA – Real World Molecular Testing, Treatment Patterns, and Clinical Outcomes EGFR Mutation-Positive NSCLC
Condition(s):Carcinoma, Non-Small-Cell LungLast Updated:May 27, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Carcinoma, Non-Small-Cell LungLast Updated:May 27, 2021Completed
Condition(s):ALK-positive NSCLCLast Updated:April 6, 2023Completed
Condition(s):Non-small-cell Lung CarcinomaLast Updated:August 25, 2023Recruiting
Condition(s):Lung Cancer Stage IV; EGFR T790MLast Updated:January 27, 2023Not yet recruiting
Condition(s):Lung Adenocarcinoma Stage III; EGFR Gene MutationLast Updated:December 23, 2022Completed
Condition(s):Lung Cancer, Non-small Cell; EGFR Gene Mutation; EGFR-TKI Resistant Mutation; Primary Resistance; Circulating Tumor DNALast Updated:August 2, 2023Recruiting
Condition(s):Leukemia, Myeloid, Chronic-Phase (CML-CP)Last Updated:September 30, 2016Completed
Condition(s):Acute Lymphocytic Leukemia, Adult B-Cell; BCR-ABL1 Fusion Protein ExpressionLast Updated:March 24, 2022Unknown status
Condition(s):Philadelphia Chromosome Positive Acute Lymphoblastic LeukemiaLast Updated:October 5, 2023Recruiting
Condition(s):Leukemia, Myeloid, Chronic-PhaseLast Updated:September 25, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.